NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) is pleased to announce that Professor Nahshon Knoller M.D., senior clinical advisor to the Company, will be ...

Including the replacement of the facial components, which used bone from Flores' hip, and left no external scarring, the ...

The King's Birthday 2025 Honours List recognises the outstanding depth of talent, dedication, and leadership across New Zealand's sport sector, says ...

The monumental achievement, in collaboration with Ernest McCulloch, opened the door to regenerative medicine and its ...

Horse therapy is becoming a crucial part of Ukraine’s healing process, helping wounded soldiers recover both physically and ...

Low back pain is the most prevalent musculoskeletal condition worldwide and is closely tied to the progressive degeneration ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...

Karla Flores was diagnosed with a rare brain tumor. A misplaced MRI found a second, nearly inoperable, tumor on her spine.

Elon Musk's brain implant company Neuralink said on Monday that it had raised $650 million in its latest funding round. It ...